What


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
03 2019
Historique:
received: 06 05 2018
accepted: 09 07 2018
pubmed: 22 7 2018
medline: 28 10 2019
entrez: 22 7 2018
Statut: ppublish

Résumé

The optimal methodology for defining response with

Identifiants

pubmed: 30030343
pii: jnumed.118.214148
doi: 10.2967/jnumed.118.214148
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

328-334

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Guy-Anne Turgeon (GA)

Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia guy-anne.turgeon@usherbrooke.ca.

Amir Iravani (A)

Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Tim Akhurst (T)

Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Alexis Beaulieu (A)

Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Jason W Callahan (JW)

Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Mathias Bressel (M)

Department of Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Aidan J Cole (AJ)

Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Centre for Cancer Research and Cell Biology, Queen's University, Belfast, Northern Ireland.

Sarah J Everitt (SJ)

Radiation Therapy, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; and.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

Shankar Siva (S)

Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

Rodney J Hicks (RJ)

Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

David L Ball (DL)

Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

Michael P Mac Manus (MP)

Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH